Somaalia to India: Metoprolol Import Trade Route

The Somaalia to India Metoprolol corridor is one of India's established pharmaceutical import routes from Somaalia, with 1 shipments documented worth a combined $1.7K USD. The route is dominated by NASRI PHARMACEUTICAL COMPANY, which alone accounts for roughly 100% of all import value, reflecting the consolidated nature of Somaalia's metoprolol export sector.

Across 1 active Somaalia suppliers, the average shipment value stands at $1.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 76% of all shipments, consistent with metoprolol's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 26 days port-to-port. The route has recorded an annual growth rate of 19.7%, placing it at rank #10 among India's top metoprolol import origins globally.

On the Indian buyer side, key Indian importers include AZKA MEDTRADE AND SERVICES. AZKA MEDTRADE AND SERVICES is the single largest Indian importer with 1 shipments valued at $1.7K USD.

India's metoprolol imports from Somaalia are driven primarily by a handful of large-scale Somaalia manufacturers. NASRI PHARMACEUTICAL COMPANY with 1 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — Indian buyers benefit from Somaalia supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — NASRI PHARMACEUTICAL COMPANY — together account for 100% of total trade value on this route. The average shipment value of $1.7K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

On the buying side, AZKA MEDTRADE AND SERVICES is the largest importer with 1 shipments worth $1.7K USD — representing 100% of all metoprolol imports from Somaalia on this route.